In 2000, John Morthanos from New Haven, CT was feeling winded and he thought he was having a heart attack because he was having trouble breathing; doctors found that his heart was fine, but there was a mysterious spot on his lung.
After numerous doctor’s visits and tests, his breathing problems were attributed to acid reflux, stress and even allergic reactions to his cats. A lung biopsy also found mild scarring.
However, John’s breathing problems became progressively worse, to the point that he couldn’t walk up the stairs without being winded and taking the trash out felt like pushing a car up a hill. It was then that John knew something was really wrong.
Finally, in 2011 after being referred to experts at Yale University, John received devastating news: he had idiopathic pulmonary fibrosis, a life-threatening disease that causes permanent and progressive scarring of the lungs.
Immediately, John, his wife Paula and his medical team developed a treatment plan, including supplemental oxygen and pulmonary rehabilitation. Because his condition was getting worse, John later received a single-lung transplant. Today, John is focused on raising awareness about IPF so others can hopefully avoid the struggles he faced securing a timely diagnosis.
A new survey uncovers the emotional and physical impact of this rare and fatal lung disease called, Idiopathic Pulmonary Fibrosis.
- On average, patients experience IPF symptoms for nearly two years before being diagnosed
- More than three-quarters of patients and caregivers affected by coughing caused by IPF say that people often keep a distance because of it; and more than half of patients and caregivers using supplemental oxygen feel that it is embarrassing to be seen with the equipment
- Signs and symptoms of IPF
- Impact of IPF on the everyday lives of patients and caregivers, according to the survey
- Why education and support may help address the needs of patients, caregivers and their doctors
LINK TO INTERVIEW with Dr. Jeffrey Swigris, Pulmonologist, and John Morthanos, IPF patient:
About Jeffrey James Swigris (pulmonologist):
National Jewish Health
Jeffrey Swigris, DO, MS, is an Associate Professor of Medicine at National Jewish Health and the University of Colorado. His clinical interest is in evaluating and caring for patients with interstitial lung disease (ILD) of any cause. Dr. Swigris’s individual research program focuses on how patients perceive living with ILD, how to assess those perceptions and how caretakers might improve quality of life in patients suffering from ILD. He was recently awarded funding for a nationwide research project: The Participation Program for Pulmonary Fibrosis or P3F (www.PFresearch.org). He is a member of the American Thoracic Society, American College of Chest Physicians and is on the Pulmonary Fibrosis Foundation’s Medical Advisory Board.
If you suspect you have any of the same symptoms as John, please visit: http://www.lungsandyou.com for more information on IPF.